Methods for the generation of multispecific and multivalent antibodies

Patent metadata

Field	Value
Publication number	US-10597465-B2
Application number	US-201715849388-A
Country	US
Kind code	B2
Filing date	Dec 20, 2017
Priority date	Aug 16, 2010
Publication date	Mar 24, 2020
Grant date	Mar 24, 2020

Abstract

The invention provides novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule and methods for producing novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule. The antibodies are composed of a single heavy chain and two different light chains, one containing a Kappa constant domain and the other of a Lambda constant domain. The invention provides methods for the isolation of antibodies of different specificities but sharing a common heavy chain. The invention also provides methods for the controlled co-expression of two light chains and a single heavy chain leading to the assembly of monospecific and bispecific antibodies. The invention provides a mean of producing a fully human bispecific and bivalent antibody that is unaltered in sequence and does not involve the use of linkers or other non-human sequences, as well as antibody mixtures of two monospecific antibodies and one bispecific antibody. The invention also provides the means of efficiently purifying the bispecific antibody.

First claim

What is claimed is:

1. A method to generate an antibody mixture comprising three or more monospecific antibodies and three or more bispecific antibodies, all having a common heavy chain, the method comprising:
a. isolating an antibody or antibody fragment region having a specificity determined by a heavy chain variable domain combined with a first light chain variable domain;
b. isolating several antibodies or antibody fragments region having a different specificity determined by the same heavy chain variable domain as the antibody of step a) combined with different light chain variable domains;
c. co-expressing in a cell:
i. a heavy chain polypeptide comprising the common heavy chain variable domain fused to an immunoglobulin heavy chain constant region;
ii. light chain polypeptides comprising all the light chains of the antibodies isolated in step a) and b) fused either to a light chain constant domain of the Kappa type or fused to a light chain constant domain of the Lambda type; and

d. recovering the heavy chain polypeptide and the light chain polypeptides, thereby generating an antibody mixture comprising three or more monospecific antibodies and three or more bispecific antibodies, all having a common heavy chain.

2. The method of claim 1 further comprising the step of (d) purifying the antibody mixture produced in step c) from cell culture supernatant.

3. The method of claim 2 , wherein the purification step is performed using Kappa constant domain specific, Lambda constant domain specific or both Kappa constant domain specific and Lambda constant domain specific affinity chromatography media.

4. The method of claim 1 , in which the steps (a) and (b) are facilitated by the use of antibody libraries having a common heavy chain and diversity confined to the light variable domain.

5. The method of claim 4 , wherein the antibody library is displayed on a filamentous bacteriophage, at the surface of yeast, bacteria or mammalian cells or used for ribosome or other type of in vitro display.

Assignees

• Novimmune Sa

Inventors

• Fischer Nicolas
• Magistrelli Giovanni
• Gueneau Franck
• Ravn Ulla
• Elson Greg

Classifications

• C07K16/249

  Interferons · CPC title

• C07K2317/32

  specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor · CPC title

• C12N15/1075

  by coupling phenotype to genotype, not provided for in other groups of this subclass · CPC title

• C07K2317/92

  Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value · CPC title

• C07K2317/31

  multispecific · CPC title